Nuzenio

Tradingview Heron Therapeutics

Tradingview Heron Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Mon, 10 Aug 2026 12:08:40 GMTHeron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook - TradingView

Mon, 10 Aug 2026 12:03:01 GMTHeron Therapeutics reports Q2 2026 revenue $37.7M, withdraws 2026 guidance after patent ruling - TradingView

Fri, 07 Aug 2026 17:00:07 GMTHeron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview - TradingView

Mon, 03 Aug 2026 11:00:37 GMTHRTX Q2'26 Earnings: revenue estimate is 42.19M USD - TradingView

Sat, 01 Aug 2026 05:02:16 GMTHeron Therapeutics, Inc. Revenue Breakdown – NASDAQ:HRTX - TradingView

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Heron Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.